Table 3.
Summary of immune-related adverse events (regardless of attribution to treatment) (N = 94)
| Immune-related adverse events, n (%) | Any grade | Grade ≥3 |
|---|---|---|
| Any | 24 (25.5) | 6 (6.4) |
| Hypothyroidism | 8 (8.5) | 0 |
| Hyperthyroidism | 4 (4.3) | 0 |
| Pruritus | 4 (4.3) | 0 |
| Pneumonitis | 3 (3.2) | 1 (1.1) |
| Rash maculopapular | 2 (2.1) | 1 (1.1) |
| Acute kidney injury | 1 (1.1) | 1 (1.1) |
| Adrenal insufficiency | 1 (1.1) | 1 (1.1) |
| Colitis | 1 (1.1) | 0 |
| Dermatitis | 1 (1.1) | 0 |
| Interstitial lung disease | 1 (1.1) | 1 (1.1) |
| Myositis | 1 (1.1) | 0 |
| Palmar-plantar erythrodysesthesia syndrome | 1 (1.1) | 0 |
| Rash | 1 (1.1) | 1 (1.1) |
| Rash erythematous | 1 (1.1) | 0 |